Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 29, 2020 - Issue 7
Submit an article Journal homepage
437
Views
4
CrossRef citations to date
0
Altmetric
Review

Enhancing venetoclax activity in hematological malignancies

Toshihisa Sattaa Division of Hematology/Oncology, Virginia Commonwealth University, Richmond, USAView further author information
&
Steven Granta Division of Hematology/Oncology, Virginia Commonwealth University, Richmond, USA;b Department of Biochemistry, Virginia Commonwealth University, Richmond, USA;c Department of Pharmacology, Virginia Commonwealth University, Richmond, USA;d Department of Molecular and Human Genetics, Virginia Commonwealth University, Richmond, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4452-9320View further author information
ORCID Icon
Pages 697-708 | Received 26 Jun 2020, Accepted 26 Jun 2020, Published online: 16 Jul 2020

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yunjian Li, Liang Du, Kaiqin Ye, Xiao Sun, Lei Hu, Shan Gao & Haiming Dai. (2023) AKT inhibition sensitizes acute leukemia cells to S63845-induced apoptosis. Hematology 28:1.
Read now
Chuanhua Cao, Yu Pei, Haiying Yu & Huixiong Qi. (2023) Dual targeting Bcl-2 and Bcl-xL augments osteosarcoma response to doxorubicin. Journal of Chemotherapy 0:0, pages 1-11.
Read now

Articles from other publishers (2)

Amol Tandon, Jissy Akkarapattiakal Kuriappan & Vaibhav Dubey. (2023) Translocation Tales: Unraveling the MYC Deregulation in Burkitt Lymphoma for Innovative Therapeutic Strategies. Lymphatics 1:2, pages 97-117.
Crossref
Shan Zhu, Jiao Liu, Rui Kang, Minghua Yang & Daolin Tang. (2021) Targeting NF-κB–dependent alkaliptosis for the treatment of venetoclax-resistant acute myeloid leukemia cells. Biochemical and Biophysical Research Communications 562, pages 55-61.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.